medline.ch Respirationstrakt Zystische Fibrose

	Extracellular vesicle-based delivery to airway basal cells for durable gene therapy in cystic fibrosis. Front Bioeng Biotechnol Ivleva A, Demchenko A, Smirnikhina S. PMID: 42529376 [PubMed]
	Forced vital capacity in pulmonary exacerbations of cystic fibrosis. J Cyst Fibros McElvaney OJ, Heltshe SL, Sanders DB, West NE, Ramos KJ, Fogarty B, Flume PA, Goss CH, STOP2 Investigators. PMID: 42521589 [PubMed - as supplied by publisher]
	The role of ETI therapy in managing sinusitis in cystic fibrosis pediatric population: A study on clinical outcomes. Respir Med Terracciano R, Cerchione R, Cimbalo C, Buonpensiero P, Di Pasqua A, De Rosa E, Di Salle F, Castaldo A, Capasso F, Tosco A, Cantone E, Sepe A. PMID: 42521036 [PubMed - as supplied by publisher]
	Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis. Pediatr Pulmonol Fava J, Stephan E, Tansmore J, Sheikh S, Eisner M, Novak KJ. PMID: 42517727 [PubMed - indexed for MEDLINE]
	FT-IR Spectroscopy to Discriminate Old from New Pseudomonas aeruginosa Infections in People with Cystic Fibrosis. Int J Mol Sci Rossitto M, Raimondi S, Fox V, Tuccio Guarna Assanti V, Essa N, Lepanto MS, Cristiano M, Cortazzo V, Agosta M, Majo F, Cutrera R, Perno CF, Bernaschi P, Vrenna G. PMID: 42511794 [PubMed - indexed for MEDLINE]
	Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management. Genes (Basel) Ke L, Guan L, Bao Y, Tang C. PMID: 42510783 [PubMed - indexed for MEDLINE]
	Evolving Cystic Fibrosis Therapy: The Good, the Sad, and the Hopeful. Children (Basel) Funken D, Grasemann H. PMID: 42509903 [PubMed]
	Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat-Soluble Vitamin Status in 2 to 5 Year-Old Children Using a Cystic Fibrosis-Specific Multivitamin Formulation. Children (Basel) Munck A, Languepin J, Enaud R, Chedevergne F, Wizla N, Remus N, Mittaine M, Bui S, Arrouy A, Quinn M, Wahlquist A, Sermet-Gaudelus I. PMID: 42509893 [PubMed]
	EASE-CF: dietitian-led weight-loss intervention for adults with cystic fibrosis and excess weight: protocol for a feasibility randomised controlled trial. BMJ Open Respir Res Snowball J, Adler A, Lally P, Talbot NP, Hedley E, Koutoukidis DA. PMID: 42508970 [PubMed - indexed for MEDLINE]
	Population Pharmacokinetic and Exposure-Response Analysis of Vancomycin Nephrotoxicity in Cystic Fibrosis Patients. Pediatr Pulmonol Barry J, van Hasselt JGC, Evans M, Hirsch EB, Dunitz J, Shockley S, Billings J, Illamola SM. PMID: 42508420 [PubMed - indexed for MEDLINE]
	Comparing Multiple Breath Washout Parameters in a Matched Cohort of Children With Cystic Fibrosis and Primary Ciliary Dyskinesia. Pediatr Pulmonol Vanvuchelen L, Vermaut A, Proesmans M, Vermeulen F, Boon M. PMID: 42504864 [PubMed - indexed for MEDLINE]
	Exploring the lived experiences of individuals with cystic fibrosis after the implementation of elexacaftor/tezacaftor/ivacaftor for treatment. Ther Adv Respir Dis Riggle A, Page A, Roesch E, Michie M, Darrah R. PMID: 42500837 [PubMed - indexed for MEDLINE]
	Impact of cystic fibrosis transmembrane conductance regulator modulator therapies on liver stiffness and liver enzymes: An observational perspective single-center cohort study. JPGN Rep Giugliano L, Augustoni E, Pizzol A, Opramolla A, Chiadò C, Zagaria A, Esposito I, Roberto G, Ponte A, Evangelista A, Quarello P, Pinon M, Calvo PL. PMID: 42499719 [PubMed - as supplied by publisher]
	Clinical features associated with Pseudomonas aeruginosa colonization in children under 2 years of age: a retrospective study of Cystic Fibrosis Registry. Turk J Pediatr Ocak E, Cinel G, Tu, Polat SE, Tural DA, Özsezen B, Yalç, Kiper N, , , Alt, K, Çoku, Yazan H, Ünal G, Y, Irmak I, Damado, Öztürk GK, Demir E, Ba, Bingöl A, Sapan N, Can, Asfuro, Aslan AT, Harmanc, Hangül M, Köse M, Özdemir A, Özcan G, Çobano, Ayd, Keskin Ö, Yüksel H, Özdo, Topal E, Çaltepe G, Can D, Korkmaz P, K, Eyübo, Pekcan S, Çak, Emiralio, Özçelik U, Do. PMID: 42497434 [PubMed - indexed for MEDLINE]
	Cystic Fibrosis Mortality Trends 1999-2024-A CDC Wonder Study. Adv Respir Med Grover P, Jain R, Kaur G, Ranjan N, Singh B. PMID: 42496256 [PubMed - indexed for MEDLINE]
	Gastrointestinal and Pancreatic Manifestations of Cystic Fibrosis in the Era of Highly Effective Modulators. Adv Pediatr Abi-Aad SJ, Narayanan S, Khalaf RT. PMID: 42481089 [PubMed - indexed for MEDLINE]
	Paradigm Shifts in Cystic Fibrosis Newborn Screening and Care in Infancy. Adv Pediatr Wyatt ML, Clarion J, McGarry M. PMID: 42481088 [PubMed - indexed for MEDLINE]
	Improvement in functional exercise performance and quadriceps muscle strength after two years treatment with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: A prospective observational study. J Cyst Fibros Aubriot AS, Song C, Gonçalvès C, Santelé L, Berardis S, Goubau C, Reychler G, Penelle M, Gohy S. PMID: 42476895 [PubMed - as supplied by publisher]
	Divergent Management of the Foregut Between Pulmonologists and Gastroenterologists in Advanced Cystic Fibrosis Lung Disease. Pediatr Pulmonol Patel D, King J, Wilder A, Al-Hammadi N, Hejazi R, Barkin J, Hachem C, Vélez C. PMID: 42473831 [PubMed - indexed for MEDLINE]
	Cone beam CT in the evaluation of paranasal sinuses in pediatric cystic fibrosis: radiological findings and dosimetric comparison with conventional maxillofacial CT in children with sinus pathology. Eur Arch Otorhinolaryngol Firetto MC, Campoleoni M, Barantani A, Cè M, Di Cicco M, Fabrizio R, Mascitti L, Cellina M, Carrafiello G. PMID: 42472935 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 20106

Seite 1 von 1006



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung